Subsequent Events

12 Months Ended

Dec. 31, 2021

Subsequent Events [Abstract]

Subsequent Events

22. Subsequent Events

Centers for Medicare & Medicaid Services (CMS) Billing Policy Notice & Rights Offering

On January 28, 2022, the Company announced that the Centers for Medicare & Medicaid Services (CMS) issued a new billing policy whereby CMS would no longer reimburse for the use of the Company’s ThyGeNEXT^® and ThyraMIR^® tests when billed together by the same provider/supplier for the same beneficiary on the same date of service and that the Company was terminating its previously announced rights offering and the mutual termination of the standby purchase agreement with 3K Limited Partnership. The CMS billing policy decision was subsequently reversed in February 2022, however the Company has not yet realized the full cash collection benefit of current and retroactive Thyroid testing and such cash collections may be temporarily reduced or delayed until we resolved the matter with CMS.

INTERPACE BIOSCIENCES, INC.

VALUATION AND QUALIFYING ACCOUNTS

YEARS ENDED DECEMBER 31, 2021 AND 2020

($ in thousands)

			Additions
	Balance at		(Reductions)		(1)			Balance at
	Beginning		Charged to		Deductions			end
Description	of Period		Operations		Other			of Period
2020
Allowance for doubtful accounts	$	25		-		250		$	275
Allowance for doubtful notes	$	869		-		-		$	869
Tax valuation allowance	$	17,027		-		6,657		$	23,684
2021
Allowance for doubtful accounts	$	275		-		(203	)	$	72
Allowance for doubtful notes	$	869		-		-		$	869
Tax valuation allowance	$	23,684		-		9,486		$	33,170

(1) Includes payments and actual write offs, as well as changes in estimates in the reserves.